BioMarin Pharmaceutical
BMRN
#1967
Rank
โ‚น991.32 B
Marketcap
โ‚น5,129
Share price
0.28%
Change (1 day)
-2.17%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): โ‚น41.10 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are โ‚น3.22 Billion. a decrease over its 2024 earnings that were of โ‚น51.40 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น45.77 B-10.94%
2024 โ‚น51.40 B187.31%
2023 โ‚น17.89 B26.07%
2022 โ‚น14.19 B-298.51%
2021 -โ‚น7.15 Billion78.04%
2020 -โ‚น4.02 Billion-55.36%
2019 -โ‚น9 Billion-33.56%
2018 -โ‚น13.54 Billion297.78%
2017 -โ‚น3.41 Billion-95.68%
2016 -โ‚น78.86 Billion437.12%
2015 -โ‚น14.69 Billion23.91%
2014 -โ‚น11.85 Billion-29.25%
2013 -โ‚น16.75 Billion49.23%
2012 -โ‚น11.23 Billion171.11%
2011 -โ‚น4.14 Billion103.01%
2010 -โ‚น2.04 Billion-3903.54%
2009 โ‚น53.6 M-98.31%
2008 โ‚น3.17 B-189.7%
2007 -โ‚น3.54 Billion51.02%
2006 -โ‚น2.35 Billion-61.58%
2005 -โ‚น6.1 Billion-56.59%
2004 -โ‚น14.04 Billion95.13%
2003 -โ‚น7.2 Billion12.09%
2002 -โ‚น6.42 Billion73.19%
2001 -โ‚น3.71 Billion18.32%
2000 -โ‚น3.14 Billion19.65%
1999 -โ‚น2.62 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚น730.50 B 1,495.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น48.3 Billion-205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น10.35 Billion-122.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น2.61 Billion-105.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น18.12 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น26.89 B-41.24%๐Ÿ‡บ๐Ÿ‡ธ USA